Physician

Jun Frank Sun, M.D.

According to 2025 Medicare claims, Jun Sun, M.D. (NPI: 1306097209) practices hematology/oncology in the Washington, DC-MD market, with the plurality of this provider's patient population coming from Prince Georges, MD. This provider's primary affiliated billing organization is MARYLAND ONCOLOGY HEMATOLOGY, P.A. (NPI: 1821271032; TIN: 113652573) and primary practice location at 20613-3045.

Sun's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 954 traditional Medicare patients, billed 233,651 HCPCS/CPT codes, and received $3,507,784 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,111 prescription claims across 185 beneficiaries totaling $3,624,823 in drug costs, led by Pomalyst (Pomalidomide). 2022 DME data shows 11 claims. Open Payments data shows 153 records totaling $3,210,515. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,148,762 to $3,507,784. Similarly, Part D prescription costs have risen steadily, from $224,878 to $3,624,823. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.3M$4.6M2015 Medicare payment: $1,148,762 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,387,536 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,669,071 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,410,676 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,807,213 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,940,650 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,576,214 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,930,561 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,874,341 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,507,784 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201576797,552$1,148,762
2016838126,319$1,387,536
2017941152,880$1,669,071
2018993197,266$2,410,676
2019895241,955$2,807,213
2020990344,165$3,940,650
20211,006373,542$4,576,214
20221,114381,201$3,930,561
20231,025334,733$3,874,341
2024954233,651$3,507,784

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.8M$3.6M2015 Drug cost: $224,878 (USD; Tot_Drug_Cst)2016 Drug cost: $291,206 (USD; Tot_Drug_Cst)2017 Drug cost: $574,260 (USD; Tot_Drug_Cst)2018 Drug cost: $1,034,541 (USD; Tot_Drug_Cst)2019 Drug cost: $827,629 (USD; Tot_Drug_Cst)2020 Drug cost: $1,286,551 (USD; Tot_Drug_Cst)2021 Drug cost: $1,589,269 (USD; Tot_Drug_Cst)2022 Drug cost: $1,855,670 (USD; Tot_Drug_Cst)2023 Drug cost: $1,908,340 (USD; Tot_Drug_Cst)2024 Drug cost: $3,624,823 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015107401$224,878
2016112469$291,206
2017108538$574,260
2018120641$1,034,541
201993560$827,629
2020110696$1,286,551
2021123792$1,589,269
2022144743$1,855,670
2023147793$1,908,340
20241851,111$3,624,823

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$20K$40K2015 Medicare payment: $39,636 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $13,760 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $9,113 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $9,114 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $3,428 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,817 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,107 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $208 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R81$39,636
2016N/R43$13,760
2017N/R34$9,113
2018N/R83$9,114
2019N/R42$3,428
2020N/R37$1,817
2021N/R12$1,107
2022N/R11$208
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more456992$112
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more340565$81
82728Ferritin (blood protein) level299725$13
80053Blood test, comprehensive group of blood chemicals3341,163$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count5012,223$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PomalystPomalidomide391,092$894,478
LenalidomideLenalidomide461,295$536,683
TagrissoOsimertinib Mesylate14420$236,777
JakafiRuxolitinib Phosphate12360$210,680
EliquisApixaban2249,857$187,459

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.143$7,415Karyopharm Therapeutics Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.10$3,203,100Aveo Pharmaceuticals, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jun Frank Sun, M.D.?

Tedicare shows public-source Medicare data for Jun Frank Sun, M.D. (NPI 1306097209), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jun Frank Sun, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jun Frank Sun, M.D.?

Jun Frank Sun, M.D. is linked to MARYLAND ONCOLOGY HEMATOLOGY, P.A. (billing NPI 1821271032) in the available physician profile data.

Does Jun Frank Sun, M.D. have Open Payments data?

Jun Frank Sun, M.D. has 153 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.